Overview

Miltefosine for Mucosal Leishmaniasis

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
This trial will study miltefosine as a treatment for mucosal leishmaniasis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
AB Foundation
Treatments:
Miltefosine